![Hilary Webber](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Hilary Webber is currently the Chairman at Eqalis Pharmaceuticals Ltd.
Previously, Ms. Webber worked as an Independent Non-Executive Director at Cannasouth Ltd.
Aktive Positionen von Hilary Webber
Unternehmen | Position | Beginn |
---|---|---|
Eqalis Pharmaceuticals Ltd
![]() Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Vorsitzender | - |
Ehemalige bekannte Positionen von Hilary Webber
Unternehmen | Position | Ende |
---|---|---|
CANNASOUTH LIMITED | Direktor/Vorstandsmitglied | 01.01.2024 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CANNASOUTH LIMITED | Health Technology |
Private Unternehmen | 1 |
---|---|
Eqalis Pharmaceuticals Ltd
![]() Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Health Technology |